RT Journal Article
SR Electronic
T1 Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008037
DO 10.1136/jitc-2023-008037
VO 12
IS 4
A1 Frentzas, Sophia
A1 Austria Mislang, Anna Rachelle
A1 Lemech, Charlotte
A1 Nagrial, Adnan
A1 Underhill, Craig
A1 Wang, Wenjing
A1 Wang, Zhongmin Maxwell
A1 Li, Baiyong
A1 Xia, Yu
A1 Coward, Jermaine I G
YR 2024
UL http://jitc.bmj.com/content/12/4/e008037.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.